Screening for EGFR mutations in lung cancer, a report from India
R Sahoo, VC Babu, GVP Okaly, S Rao, A Nargund… - Lung cancer, 2011 - Elsevier
Epidermal growth factor receptor (EGFR) is one of the targeted molecular markers in many
cancers including the lung malignancy. Genetic modifications such as deletions, insertions …
cancers including the lung malignancy. Genetic modifications such as deletions, insertions …
Mutational analysis of EGFR mutations in non-small cell lung carcinoma—an Indian perspective of 212 patients
AK Kaler, K Patel, H Patil, Y Tiwarekar… - International Journal of …, 2022 - mdpi.com
Lung cancer is the world's leading cause of cancer-related deaths. Epidermal growth factor
receptor (EGFR) is one of the critical oncogenes and plays a significant role in tumor …
receptor (EGFR) is one of the critical oncogenes and plays a significant role in tumor …
Epidermal growth factor receptor mutation in non-small-cell lung carcinomas: A retrospective analysis of 1036 lung cancer specimens from a network of tertiary cancer …
VH Veldore, RM Rao, S Kakara… - Indian Journal of …, 2013 - journals.lww.com
BACKGROUND: Epidermal growth factor receptor (EGFR) mutation plays a vital role in the
prognosis of patients with lung cancer. However, there is a dearth of studies on EGFR …
prognosis of patients with lung cancer. However, there is a dearth of studies on EGFR …
The efficacy of EGFR gene mutation testing in various samples from non-small cell lung cancer patients: a multicenter retrospective study
P Krawczyk, R Ramlau… - Journal of cancer …, 2015 - Springer
Introduction Testing for the epidermal growth factor receptor (EGFR) gene mutations
requires considerable multidisciplinary experience of clinicians (for appropriate patient …
requires considerable multidisciplinary experience of clinicians (for appropriate patient …
EGFR mutation status in Middle Eastern patients with non-squamous non-small cell lung carcinoma: A single institution experience
Background Epidermal growth factor receptor (EGFR) represents an important molecular
target in the treatment of lung adenocarcinomas; many anti-EGFR therapies are approved …
target in the treatment of lung adenocarcinomas; many anti-EGFR therapies are approved …
The prevalence of EGFR mutations in non‐small cell lung cancer in an unselected Caucasian population
BG Skov, E Høgdall, P Clementsen, M Krasnik… - Apmis, 2015 - Wiley Online Library
EGFR mutation frequencies in unselected Caucasian populations are unknown. This study
assesses the prevalence of EGFR mutations in an unselected population‐based cohort, and …
assesses the prevalence of EGFR mutations in an unselected population‐based cohort, and …
Molecular epidemiological prospective study of EGFR mutations from Asian patients (pts) with advanced lung adenocarcinoma (PIONEER).
PC Yang, Y Shi, JS Au, S Srinivasan, GH Cornelio… - 2012 - ascopubs.org
1534 Background: The epidemiological, multicenter prospective study (NCT01185314;
PIONEER) assessed EGFR mutation (M) rates in pts from Asia with newly diagnosed …
PIONEER) assessed EGFR mutation (M) rates in pts from Asia with newly diagnosed …
[HTML][HTML] A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non–small-cell lung cancer of adenocarcinoma histology …
Y Shi, JSK Au, S Thongprasert, S Srinivasan… - Journal of thoracic …, 2014 - Elsevier
Introduction: PIONEER (NCT01185314) was a prospective, multinational, epidemiological
study of epidermal growth factor receptor (EGFR) mutations in patients from Asia with newly …
study of epidermal growth factor receptor (EGFR) mutations in patients from Asia with newly …
EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples
G Ellison, G Zhu, A Moulis, S Dearden… - Journal of clinical …, 2013 - jcp.bmj.com
Aims Activating mutations in the gene encoding epidermal growth factor receptor (EGFR)
can confer sensitivity to EGFR tyrosine kinase inhibitors such as gefitinib in patients with …
can confer sensitivity to EGFR tyrosine kinase inhibitors such as gefitinib in patients with …
[HTML][HTML] Clinicopathologic characteristics of the EGFR gene mutation in non–small cell lung cancer
AS Tsao, XM Tang, B Sabloff, L Xiao… - Journal of Thoracic …, 2006 - Elsevier
Background The authors sought to define clinicopathologic features associated with
mutations of the epidermal growth factor receptor (EGFR) gene in non–small cell lung …
mutations of the epidermal growth factor receptor (EGFR) gene in non–small cell lung …
相关搜索
- screening for egfr mutations
- prevalence of egfr mutations
- small cell lung cancer
- cell lung cancer patients
- growth factor lung adenocarcinoma
- asian patients egfr mutations
- indian perspective egfr mutations
- egfr mutation testing
- adenocarcinoma histology egfr mutations
- egfr mutation status
- receptor mutation lung adenocarcinoma
- cytology samples lung cancer
- tumour tissue lung cancer
- lung cancer specimens
- egfr gene mutation
- retrospective analysis lung carcinomas